ATE390149T1 - Topische emulsionsgel-zubereitung enthaltend diclofenac-natrium - Google Patents

Topische emulsionsgel-zubereitung enthaltend diclofenac-natrium

Info

Publication number
ATE390149T1
ATE390149T1 AT03792412T AT03792412T ATE390149T1 AT E390149 T1 ATE390149 T1 AT E390149T1 AT 03792412 T AT03792412 T AT 03792412T AT 03792412 T AT03792412 T AT 03792412T AT E390149 T1 ATE390149 T1 AT E390149T1
Authority
AT
Austria
Prior art keywords
preparation containing
diclofenac sodium
gel preparation
emulsion gel
containing diclofenac
Prior art date
Application number
AT03792412T
Other languages
English (en)
Inventor
Michel Steiger
Original Assignee
Novartis Consumer Health Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=31896841&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE390149(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Consumer Health Sa filed Critical Novartis Consumer Health Sa
Application granted granted Critical
Publication of ATE390149T1 publication Critical patent/ATE390149T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AT03792412T 2002-08-22 2003-08-21 Topische emulsionsgel-zubereitung enthaltend diclofenac-natrium ATE390149T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02018772 2002-08-22

Publications (1)

Publication Number Publication Date
ATE390149T1 true ATE390149T1 (de) 2008-04-15

Family

ID=31896841

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03792412T ATE390149T1 (de) 2002-08-22 2003-08-21 Topische emulsionsgel-zubereitung enthaltend diclofenac-natrium

Country Status (16)

Country Link
US (3) US7732489B2 (de)
EP (1) EP1536836B1 (de)
AR (1) AR041021A1 (de)
AT (1) ATE390149T1 (de)
AU (1) AU2003264086B2 (de)
BR (1) BR0313701A (de)
CA (1) CA2496469C (de)
DE (1) DE60319997T2 (de)
DK (1) DK1536836T3 (de)
ES (1) ES2300645T3 (de)
MX (1) MXPA05002077A (de)
PE (1) PE20040321A1 (de)
PT (1) PT1536836E (de)
SI (1) SI1536836T1 (de)
TW (1) TWI316857B (de)
WO (1) WO2004017998A2 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1588697A1 (de) * 2004-04-16 2005-10-26 Kurt H. Prof. Dr. Bauer Emulsiongel für die topische Anwendung von Arzneimittel
FR2882552B1 (fr) * 2005-02-25 2008-12-26 Galderma Sa Gel aqueux de haute stabilite a base de metronidazole et procedes pour leur preparation
WO2006116661A2 (en) * 2005-04-27 2006-11-02 Avocet Polymer Technologies, Inc. Polyethylene glycol based composition for topical treatment of a closed wound with therapeutic pharmaceuticals
WO2008032227A2 (en) 2006-09-11 2008-03-20 Biomas, Ltd. Topical formulations of tellurium-containing compounds
CA2666398C (en) 2006-10-17 2015-08-18 Ed Kisak Diclofenac gel
GB0704846D0 (en) 2007-03-13 2007-04-18 Futura Medical Dev Ltd Topical pharmaceutical formulation
DE102007034976A1 (de) * 2007-07-26 2009-01-29 Bayer Healthcare Ag Arzneimittel zur transdermalen Anwendung bei Tieren
EP2055298A1 (de) 2007-10-30 2009-05-06 Novartis AG Topische Zusammensetzung
US20100099766A1 (en) * 2008-10-16 2010-04-22 Novartis Ag Topical NSAID compositions having sensate component
US20100100060A1 (en) * 2008-10-17 2010-04-22 Novartis Ag Applicator for pharmaceutical product and method of using same
DE102009008094A1 (de) * 2009-02-09 2010-08-19 Barnikol-Keuten, Doris, Dr. In situ Haft-Gelbildende Zubereitungen, insbesondere zur topischen Anwendung auf befeuchtete Haut/Schleimhaut
US8546450B1 (en) 2009-03-31 2013-10-01 Nuvo Research Inc. Treatment of pain with topical diclofenac compounds
US8618164B2 (en) 2009-03-31 2013-12-31 Nuvo Research Inc. Treatment of pain with topical diclofenac compounds
AU2010233343A1 (en) 2009-04-08 2011-10-27 Cadila Healthcare Limited Stable pharmaceutical compositions of diclofenac
RU2012129527A (ru) * 2009-12-16 2014-01-27 Шасун Фармасьютикалз Лимитед Композиция трансдермального гидрогеля дексибупрофена
US9713590B2 (en) 2011-07-28 2017-07-25 Cadila Healthcare Limited Method for treatment of pain and inflammation
ITMI20121205A1 (it) 2012-07-11 2014-01-12 Glycores 2000 Srl Composizione con attivita' antinfiammatoria ed analgesica da somministrare per uso esterno mediante vaporizzazione
BR112015000329A2 (pt) 2012-07-12 2017-06-27 Ferring Bv formulações de diclofenac
CN106604717B (zh) 2014-09-10 2020-09-11 Gsk消费者健康有限公司 局部用双氯芬酸钠组合物
GB201502845D0 (en) * 2015-02-20 2015-04-08 Futura Medical Dev Ltd Topical pharmaceutical formulation
JP6598619B2 (ja) * 2015-09-28 2019-10-30 株式会社ポーラファルマ 物性で特定される皮膚外用剤
FR3064495B1 (fr) * 2017-03-31 2021-04-02 Total Marketing Services Composition a base d'uree pour le traitement des gaz d'echappement
WO2023052599A1 (en) 2021-10-01 2023-04-06 Nutrition & Biosciences Usa 1, Llc Hydrocolloid blend compositions for topical application
EP4499036A1 (de) 2022-03-25 2025-02-05 Glycores 2000 srl Topische pharmazeutische zusammensetzung mit entzündungshemmender und schmerzlindernder wirkung und verwendungen davon
US20250099369A1 (en) 2023-09-27 2025-03-27 Andros Pharmaceuticals Co., Ltd. Topical delivery compositions comprising non-steroidal anti-inflammatory drugs

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH655656B (de) 1982-10-07 1986-05-15
CA2058975C (en) * 1990-10-30 2000-06-06 Shuichi Kasai Antiinflammatory gel preparation
JPH06509099A (ja) * 1991-07-03 1994-10-13 サノ・コーポレーシヨン ジクロフエナツクの経皮デリバリーに対する組成物及び方法
US5399342A (en) * 1993-02-03 1995-03-21 Dow Corning Corporation Cosmetics with enhanced durability
KR19990082208A (ko) * 1996-02-07 1999-11-25 오이시 고지 디클로페낙 나트륨의 투명 수용액 및 이를 이용한 의약 조성물
DE69819748T2 (de) * 1997-09-12 2004-09-30 Columbia Laboratories (Bermuda) Ltd. Arzneimittel zur behandlung von dysmenorrhöe und verfrühten wehen
TWI290464B (en) 2000-09-01 2007-12-01 Novartis Consumer Health Sa Treatment of burns
GB0108082D0 (en) 2001-03-30 2001-05-23 Novartis Consumer Health Sa Topical composition

Also Published As

Publication number Publication date
US8716340B2 (en) 2014-05-06
TWI316857B (en) 2009-11-11
BR0313701A (pt) 2005-06-28
MXPA05002077A (es) 2005-06-08
US20100234462A1 (en) 2010-09-16
WO2004017998A3 (en) 2004-04-01
US7732489B2 (en) 2010-06-08
TW200409646A (en) 2004-06-16
US20050239894A1 (en) 2005-10-27
WO2004017998A2 (en) 2004-03-04
EP1536836B1 (de) 2008-03-26
DE60319997T2 (de) 2009-04-30
AR041021A1 (es) 2005-04-27
PE20040321A1 (es) 2004-07-15
DK1536836T3 (da) 2008-07-21
US20140045942A1 (en) 2014-02-13
PT1536836E (pt) 2008-05-09
AU2003264086B2 (en) 2007-01-04
SI1536836T1 (sl) 2008-08-31
ES2300645T3 (es) 2008-06-16
EP1536836A2 (de) 2005-06-08
CA2496469C (en) 2011-07-05
DE60319997D1 (de) 2008-05-08
CA2496469A1 (en) 2004-03-04
AU2003264086A1 (en) 2004-03-11
US8557870B2 (en) 2013-10-15

Similar Documents

Publication Publication Date Title
DK1536836T3 (da) Topisk emulsionsgelsammensætning indeholdende diclofenacnatrium
NO343756B1 (no) Gelformulering med oksybutynin for utildekket topisk anvendelse
EP1648362A4 (de) Therapeutische mittel mit film
KR20050009999A (ko) 약제학적 제제
DE60324099D1 (de) Arzneistoffhaltiger tampon
NO20052914D0 (no) Terapeutiske forbindelser
PT1501534E (pt) Formulacoes farmaceuticas
DE60324178D1 (de) THIAZOLIDIN-4-ONES UM hYAK3 PROTEINEN ZU HEMMEN
FIU20020500U0 (fi) Tamsulosiinia sisältävät farmaseuttiset pelletit
DE50301661D1 (de) Darreichungsform von Ibuprofen-Natrium
DK3384931T3 (da) Superfin formoterolformulering
ATE481966T1 (de) Polyacrylfilm formende zubereitungen
EP1541371A4 (de) Applikator
EP1585532A4 (de) Topische infektionshemmende formulierungen
DK1622612T3 (da) Farmaceutisk formulering af natriumsaltet af telmitarsan
PT1513514E (pt) Formulações tópicas de hidroximatairesinol
DE60316102D1 (de) Einkomponentige Organopolysiloxangelzusammensetzung
NO20052952D0 (no) Farmasoytisk sammensetning som innbefatter mikropartikler
DK1643976T3 (da) Farmaceutisk formulering omfattende levothyroxinnatrium
DK1611884T3 (da) Plaster, indeholdende diclofenac
DE602004022688D1 (de) Reflektierender film
NO20005758D0 (no) Farmasöytisk preparat som inneholder levotyroksin-natrium
DE60335019D1 (de) Topische hautpräparate
DE60326998D1 (de) Orale zubereitung
IS7715A (is) Nýjar lyfjasamsetningar úr módafíníl

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1536836

Country of ref document: EP